Restarting Antiplatelet After ICH Cuts Recurrence Risk in Half

Restarting antiplatelet therapy after intracranial hemorrhage remains controversial, but new evidence suggests aspirin or clopidogrel can significantly reduce recurrent ICH without increased bleeding.
Medscape Medical News

Source link

Related posts

Bladder training for urinary tract symptoms in Parkinson disease: A randomized controlled trial


Adiposity is related to cerebrovascular and brain volumetry outcomes in the RUN DMC study


What's happening in Neurology(R) Neuroimmunology & Neuroinflammation


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World